Cargando…
Revealing brain pathologies with multimodal visible light optical coherence microscopy and fluorescence imaging
We present a multimodal visible light optical coherence microscopy (OCM) and fluorescence imaging (FI) setup. Specification and phantom measurements were performed to characterize the system. Two applications in neuroimaging were investigated. First, curcumin-stained brain slices of a mouse model of...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society of Photo-Optical Instrumentation Engineers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977170/ https://www.ncbi.nlm.nih.gov/pubmed/31240898 http://dx.doi.org/10.1117/1.JBO.24.6.066010 |
_version_ | 1783490449482186752 |
---|---|
author | Lichtenegger, Antonia Gesperger, Johanna Kiesel, Barbara Muck, Martina Eugui, Pablo Harper, Danielle J. Salas, Matthias Augustin, Marco Merkle, Conrad W. Hitzenberger, Christoph K. Widhalm, Georg Woehrer, Adelheid Baumann, Bernhard |
author_facet | Lichtenegger, Antonia Gesperger, Johanna Kiesel, Barbara Muck, Martina Eugui, Pablo Harper, Danielle J. Salas, Matthias Augustin, Marco Merkle, Conrad W. Hitzenberger, Christoph K. Widhalm, Georg Woehrer, Adelheid Baumann, Bernhard |
author_sort | Lichtenegger, Antonia |
collection | PubMed |
description | We present a multimodal visible light optical coherence microscopy (OCM) and fluorescence imaging (FI) setup. Specification and phantom measurements were performed to characterize the system. Two applications in neuroimaging were investigated. First, curcumin-stained brain slices of a mouse model of Alzheimer’s disease were examined. Amyloid-beta plaques were identified based on the fluorescence of curcumin, and coregistered morphological images of the brain tissue were provided by the OCM channel. Second, human brain tumor biopsies retrieved intraoperatively were imaged prior to conventional neuropathologic work-up. OCM revealed the three-dimensional structure of the brain parenchyma, and FI added the tumor tissue-specific contrast. Attenuation coefficients computed from the OCM data and the florescence intensity values were analyzed and showed a statistically significant difference for 5-aminolevulinic acid (5-ALA)-positive and -negative brain tissues. OCM findings correlated well with malignant hot spots within brain tumor biopsies upon histopathology. The combination of OCM and FI seems to be a promising optical imaging modality providing complementary contrast for applications in the field of neuroimaging. |
format | Online Article Text |
id | pubmed-6977170 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Society of Photo-Optical Instrumentation Engineers |
record_format | MEDLINE/PubMed |
spelling | pubmed-69771702020-02-03 Revealing brain pathologies with multimodal visible light optical coherence microscopy and fluorescence imaging Lichtenegger, Antonia Gesperger, Johanna Kiesel, Barbara Muck, Martina Eugui, Pablo Harper, Danielle J. Salas, Matthias Augustin, Marco Merkle, Conrad W. Hitzenberger, Christoph K. Widhalm, Georg Woehrer, Adelheid Baumann, Bernhard J Biomed Opt Imaging We present a multimodal visible light optical coherence microscopy (OCM) and fluorescence imaging (FI) setup. Specification and phantom measurements were performed to characterize the system. Two applications in neuroimaging were investigated. First, curcumin-stained brain slices of a mouse model of Alzheimer’s disease were examined. Amyloid-beta plaques were identified based on the fluorescence of curcumin, and coregistered morphological images of the brain tissue were provided by the OCM channel. Second, human brain tumor biopsies retrieved intraoperatively were imaged prior to conventional neuropathologic work-up. OCM revealed the three-dimensional structure of the brain parenchyma, and FI added the tumor tissue-specific contrast. Attenuation coefficients computed from the OCM data and the florescence intensity values were analyzed and showed a statistically significant difference for 5-aminolevulinic acid (5-ALA)-positive and -negative brain tissues. OCM findings correlated well with malignant hot spots within brain tumor biopsies upon histopathology. The combination of OCM and FI seems to be a promising optical imaging modality providing complementary contrast for applications in the field of neuroimaging. Society of Photo-Optical Instrumentation Engineers 2019-06-25 2019-06 /pmc/articles/PMC6977170/ /pubmed/31240898 http://dx.doi.org/10.1117/1.JBO.24.6.066010 Text en © The Authors. Published by SPIE under a Creative Commons Attribution 4.0 Unported License. Distribution or reproduction of this work in whole or in part requires full attribution of the original publication, including its DOI. |
spellingShingle | Imaging Lichtenegger, Antonia Gesperger, Johanna Kiesel, Barbara Muck, Martina Eugui, Pablo Harper, Danielle J. Salas, Matthias Augustin, Marco Merkle, Conrad W. Hitzenberger, Christoph K. Widhalm, Georg Woehrer, Adelheid Baumann, Bernhard Revealing brain pathologies with multimodal visible light optical coherence microscopy and fluorescence imaging |
title | Revealing brain pathologies with multimodal visible light optical coherence microscopy and fluorescence imaging |
title_full | Revealing brain pathologies with multimodal visible light optical coherence microscopy and fluorescence imaging |
title_fullStr | Revealing brain pathologies with multimodal visible light optical coherence microscopy and fluorescence imaging |
title_full_unstemmed | Revealing brain pathologies with multimodal visible light optical coherence microscopy and fluorescence imaging |
title_short | Revealing brain pathologies with multimodal visible light optical coherence microscopy and fluorescence imaging |
title_sort | revealing brain pathologies with multimodal visible light optical coherence microscopy and fluorescence imaging |
topic | Imaging |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977170/ https://www.ncbi.nlm.nih.gov/pubmed/31240898 http://dx.doi.org/10.1117/1.JBO.24.6.066010 |
work_keys_str_mv | AT lichteneggerantonia revealingbrainpathologieswithmultimodalvisiblelightopticalcoherencemicroscopyandfluorescenceimaging AT gespergerjohanna revealingbrainpathologieswithmultimodalvisiblelightopticalcoherencemicroscopyandfluorescenceimaging AT kieselbarbara revealingbrainpathologieswithmultimodalvisiblelightopticalcoherencemicroscopyandfluorescenceimaging AT muckmartina revealingbrainpathologieswithmultimodalvisiblelightopticalcoherencemicroscopyandfluorescenceimaging AT euguipablo revealingbrainpathologieswithmultimodalvisiblelightopticalcoherencemicroscopyandfluorescenceimaging AT harperdaniellej revealingbrainpathologieswithmultimodalvisiblelightopticalcoherencemicroscopyandfluorescenceimaging AT salasmatthias revealingbrainpathologieswithmultimodalvisiblelightopticalcoherencemicroscopyandfluorescenceimaging AT augustinmarco revealingbrainpathologieswithmultimodalvisiblelightopticalcoherencemicroscopyandfluorescenceimaging AT merkleconradw revealingbrainpathologieswithmultimodalvisiblelightopticalcoherencemicroscopyandfluorescenceimaging AT hitzenbergerchristophk revealingbrainpathologieswithmultimodalvisiblelightopticalcoherencemicroscopyandfluorescenceimaging AT widhalmgeorg revealingbrainpathologieswithmultimodalvisiblelightopticalcoherencemicroscopyandfluorescenceimaging AT woehreradelheid revealingbrainpathologieswithmultimodalvisiblelightopticalcoherencemicroscopyandfluorescenceimaging AT baumannbernhard revealingbrainpathologieswithmultimodalvisiblelightopticalcoherencemicroscopyandfluorescenceimaging |